Divi's Laboratories Ltd. - Research Center
532488 DIVISLAB Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 11,638.26 | 9,218.48 | 7,263.60 | 6,920.22 | 5,906.56 |
| Loan funds | |||||
| Secured loans | - | 0.35 | 33.63 | 105.60 | 63.11 |
| Unsecured loans | - | - | - | - | - |
| Total | 11,691.35 | 9,271.92 | 7,350.32 | 7,078.91 | 6,022.76 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 5,599.99 | 4,670.94 | 3,496.51 | 2,624.60 | 2,366.89 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 1,279.02 | 971.93 | 720.25 | 537.16 | 371.01 |
| Net block | 4,320.97 | 3,699.01 | 2,776.26 | 2,087.44 | 1,995.88 |
| Capital work-in-progress | 469.93 | 710.62 | 919.69 | 491.91 | 119.76 |
| Investments | 79.37 | 7.37 | 978.72 | 1,952.96 | 1,896.66 |
| Net current assets | |||||
| Current assets, loans & advances | 8,437.59 | 6,306.77 | 3,839.44 | 3,507.87 | 2,795.48 |
| Less : current liabilities & provisions | 1,616.51 | 1,451.85 | 1,163.79 | 961.27 | 785.02 |
| Total net current assets | 6,821.08 | 4,854.92 | 2,675.65 | 2,546.60 | 2,010.46 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 11,691.35 | 9,271.92 | 7,350.32 | 7,078.91 | 6,022.76 |
| Notes: | |||||
| Book value of unquoted investments | 79.37 | 7.37 | 7.37 | 7.37 | 7.37 |
| Market value of quoted investments | - | - | 971.35 | 1,945.59 | 1,889.29 |
| Contingent liabilities | 1,259.90 | 1,107.13 | 1,223.83 | 1,031.35 | 278.90 |
| Number of equity sharesoutstanding (Lacs) | 2654.69 | 2654.69 | 2654.69 | 2654.69 | 2654.69 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis